Cagrilintide
Cagrilintide is a long-acting amylin analog studied for its interaction with amylin receptors and metabolic regulation pathways [1,2].
This peptide is for research purposes only. Not for human consumption.
Description
Amylin Receptor Signaling
Research focuses on how cagrilintide engages amylin receptors involved in appetite control and gastric signaling pathways [1].
Metabolic Regulation Context
Studies explore amylin-related signaling in energy balance, glucose regulation markers, and central appetite pathways [2].
Analog Design Considerations
Structural modifications improve peptide stability and allow extended signaling analysis in metabolic research models [1].
Key Specs
• Peptide class: amylin analog
• Research context: metabolic and appetite signaling
• References: PubMed [1,2]
Referenced Citations
- PubMed, Cagrilintide pharmacology: https://pubmed.ncbi.nlm.nih.gov/34450248/
- PubMed, Amylin receptor signaling: https://pubmed.ncbi.nlm.nih.gov/19640841/
Amylin Receptor Signaling
Research focuses on how cagrilintide engages amylin receptors involved in appetite control and gastric signaling pathways [1].
Metabolic Regulation Context
Studies explore amylin-related signaling in energy balance, glucose regulation markers, and central appetite pathways [2].
Analog Design Considerations
Structural modifications improve peptide stability and allow extended signaling analysis in metabolic research models [1].
Key Specs
• Peptide class: amylin analog
• Research context: metabolic and appetite signaling
• References: PubMed [1,2]
Referenced Citations
- PubMed, Cagrilintide pharmacology: https://pubmed.ncbi.nlm.nih.gov/34450248/
- PubMed, Amylin receptor signaling: https://pubmed.ncbi.nlm.nih.gov/19640841/
Reviews
There are no reviews yet.